Ingenuity pathways analysis of urine metabonomics phenotypes toxicity of gentamicin in multiple organs

Molecular BioSystems

Volumn 6, Issue 10, 2010, Pages 2056-2067

  Lv, Haitao ^a   Liu, Lian ^b   Zhang, Yingzhi ^c   Song, Ting ^c   Lu, Juan ^c   Chen, Xi ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^c INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

ANIMAL; ARTICLE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; PHENOTYPE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, LIQUID; GENTAMICINS; MASS SPECTROMETRY; METABOLOMICS; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77956535305     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c0mb00064g     Document Type: Article

References (44)

1. M. A. Baxter C. Rowe J. Alder S. Harrison K. P. Hanley B. K. Park N. R. Kitteringham C. E. Goldring N. A. Hanley Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening Stem Cell Res. 2010
2. K. J. Boudonck M. W. Mitchell L. Német L. Keresztes A. Nyska D. Shinar M. Rosenstock Discovery of metabolomics biomarkers for early detection of nephrotoxicity Toxicol. Pathol. 2009 37 280 92
3. S. E. Friedman, J. H. Grendell and K. R. McQuaid, Current Diagnosis & Treatment in Gastroenterology, Lang Medical Books/McGraw-Hill, New York, 2003, pp. 664-679, ISBN 0-8385-1551-7
4. P. F. McNally, GI/Liver Secrets: with STUDENT CONSULT Access, C. V. Mosby, Saint Louis, 2006, ISBN 1-56053-618-7
5. G. Ostapowicz R. J. Fontana F. V. Schiødt A. Larson T. J. Davern S. H. Han T. M. McCashland A. O. Shakil J. E. Hay L. Hynan J. S. Crippin A. T. Blei G. Samuel J. Reisch W. M. Lee Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann. Intern. Med. 2002 137 947 54
6. Y. Cui R. S. Paules Use of transcriptomics in understanding mechanisms of drug-induced toxicity Pharmacogenomics 2010 11 573 85
7. Y. Tonomura N. Tsuchiya M. Torii T. Uehara Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats Toxicology 2010 273 53 59
8. S. K. Thukral P. J. Nordone R. Hu L. Sullivan E. Galambos V. D. Fitzpatrick L. Healy M. B. Bass M. E. Cosenza C. A. Afshari Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers Toxicol. Pathol. 2005 33 343 55
9. F. Dieterle E. Perentes A. Cordier D. R. Roth P. Verdes O. Grenet S. Pantano P. Moulin D. Wahl A. Mahl P. End F. Staedtler F. Legay K. Carl D. Laurie S. D. Chibout J. Vonderscher G. Maurer Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury Nat. Biotechnol. 2010 28 463 469
10. F. Wöhler Ueber die künstliche Bildung des Harnstoffe. Poggendorfs Ann. Phys. Chem. 1828 12 253 256
11. M. Adler D. Hoffmann H. Ellinger-Ziegelbauer P. Hewitt K. Matheis L. Mulrane W. M. Gallagher J. J. Callanan L. Suter M. M. Fountoulakis W. Dekant A. Mally Assessment of candidate biomarkers of drug-induced hepatobiliary injury in preclinical toxicity studies Toxicol. Lett. 2010 196 1 11
12. K. Hamden S. Carreau F. Ayadi H. Masmoudi A. El Feki Inhibitory effect of estrogens, phytoestrogens, and caloric restriction on oxidative stress and hepato-toxicity in aged rats Biomed. Environ. Sci. 2009 22 381 387
13. A. Hagiwara N. Imai T. Numano H. Nakashima S. Tamano K. Sakaue K. Tanaka K. Yasuhara S. M. Hayashi A twenty eight-day repeated dose toxicity study of black soybean extract in Sprague-Dawley rats J. Toxicol. Sci. 2010 35 87 96
14. S. Vangala A. Tonelli Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity? AAPS J. 2007 9 E284
15. M. E. Bollard H. C. Keun O. Beckonert T. M. Ebbels H. Antti A. W. Nicholls J. P. Shockcor G. H. Cantor G. Stevens J. C. Lindon E. Holmes J. K. Nicholson Comparative metabonomics of differential hydrazine toxicity in the rat and mouse Toxicol. Appl. Pharmacol. 2005 204 135 151
16. P. J. Foxall J. M. Singer J. M. Hartley G. H. Neild M. Lapsley J. K. Nicholson R. L. Souhami Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy Clin. Cancer. Res. 1997 3 1507 1518
17. T. A. Clayton J. C. Lindon J. R. Everett C. Charuel G. Hanton J. L. Le Net J. P. Provost J. K. Nicholson Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: their relationship to one another, to liver damage and to weakened nutritional status Arch. Toxicol. 2004 78 86 96
18. R. J. Mortishire-Smith G. L. Skiles J. W. Lawrence S. Spence A. W. Nicholls B. A. Johnson J. K. Nicholson Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity Chem. Res. Toxicol. 2004 17 165 173
19. H. C. Keun Metabonomic modeling of drug toxicity Pharmacol. Ther. 2006 109 92 106
20. J. C. Lindon E. Holmes M. E. Bollard E. G. Stanley J. K. Nicholson Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis Biomarkers 2004 9 1 31
21. A. Sreekumar L. M. Poisson T. M. Rajendiran A. P. Khan Q. Cao J. Yu B. Laxman R. Mehra R. J. Lonigro Y. Li M. K. Nyati A. Ahsan S. Kalyana-Sundaram B. Han X. Cao J. Byun G. S. Omenn D. Ghosh S. Pennathur D. C. Alexander A. Berger J. R. Shuster J. T. Wei S. Varambally C. Beecher A. M. Chinnaiyan Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009 457 910 914
22. X. J. Wang H. T. Lv H. Sun L. Liu B. Yang W. J. Sun P. Wang D. X. Zhou L. Zhao S. S. Dou G. M. Zhang H. X. Cao Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry J. Pharm. Biomed. Anal. 2008 48 1161 1168
23. D. P. Sundin R. Sandoval B. A. Molitoris Gentamicin Inhibits Renal Protein and Phospholipid Metabolism in Rats: Implications Involving Intracellular Trafficking J. Am. Soc. Nephrol. 2001 12 114 123
24. E. Ozbek M. Cekmen Y. O. Ilbey A. Simsek E. C. Polat A. Somay Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways Renal Failure 2009 31 382 392
25. M. Sieber D. Hoffmann M. Adler V. S. Vaidya M. Clement J. V. Bonventre N. Zidek E. Rached A. Amberg J. J. Callanan W. Dekant A. Mally Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity Toxicol. Sci. 2009 109 336 49
26. J. Zhang P. L. Goering P. Espandiari M. Shaw J. V. Bonventre V. S. Vaidya R. P. Brown J. Keenan C. G. Kilty N. Sadrieh J. P. Hanig Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine Toxicol. Pathol. 2009 37 629 43
27. K. Akira E. Negishi C. Yamamoto S. Baba Evaluation of liver function by co-administration methodology using 13C-labelled benzoic acid and hippuric acid coupled with nuclear magnetic resonance spectroscopy J. Pharm. Pharmacol. 1997 49 1242-7
28. S. Halligan S. J. Byard A. J. Spencer T. J. Gray E. S. Harpur F. W. Bonner A study of the nephrotoxicity of three cephalosporins in rabbits using 1H NMR spectroscopy Toxicol. Lett. 1995 81 15 21
29. J. A. Timbrell C. J. Waterfield R. P. Draper Use of urinary taurine and creatine as biomarkers of organ dysfunction and metabolic perturbations Comp. Haematol. Int. 1995 5 112 119
30. N. J. Waters C. J. Waterfield R. D. Farrant E. Holmes J. K. Nicholson Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis J. Proteome Res. 2006 5 1448 1459 (Pubitemid 43865813)
31. L. Cottret D. Wildridge F. Vinson M. P. Barrett H. Charles M. F. Sagot F. Jourdan MetExplore: a web server to link metabolomic experiments and genome-scale metabolic networks Nucleic Acids Res. 2010
32. A. Nehmé E. K. Lobenhofer W. D. Stamer J. L. Edelman Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells BMC Med. Genomics 2009 2 58
33. V. Schmitz J. Klawitter J. Bendrick-Peart W. Schoening G. Puhl M. Haschke J. Klawitter J. Consoer C. J. Rivard L. Chan Z. V. Tran D. Leibfritz U. Christians Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation Nephron Exp. Nephrol. 2009 111 e80 91
34. N. J. Waters C. J. Waterfield R. D. Farrant E. Holmes J. K. Nicholson Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity Chem. Res. Toxicol. 2005 18 639 54
35. V. S. Bhave S. Donthamsetty J. R. Latendresse H. M. Mehendale Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A2-mediated progression of acute liver injury Toxicol. Appl. Pharmacol. 2008 228 239 246
36. H. Liu W. Wei X. Li Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum Prostaglandins Other Lipid Mediators 2009 88 63 67
37. M. Takano H. Nishimura Y. Kimura J. Washizu Y. Mokuno Y. Nimura Y. Yoshikai Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice J. Immunol. 1998 161 3019 3025
38. A. K. Batta R. Arora G. Salen G. S. Tint D. Eskreis S. Katz Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment J. Lipid Res. 1989 30 1953 1962
39. J. L. Smith P. J. Lewindon A. C. Hoskins T. N. Pereira K. D. Setchell N. C. O'Connell R. W. Shepherd G. A. Ramm Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis Hepatology 2004 39 1673 82
40. H. E. Bays D. J. Rader Does nicotinic acid (niacin) lower blood pressure? Int. J. Clin. Pract. 2009 63 151 159
41. D. L. Maccubbin W. Sirah A. Betteridge Lipid-altering efficacy and tolerability profile of extended release niacin/laropiprant in patients with primary hypercholesterolemia or mixed hyperlipidemia (abstract) Eur. Heart. J. 2007 28 108
42. A. Nagalski J. Bryła Niacin in therapy Postepy Hig Med Dosw (Online) 2007 15 288 302
43. W. M. Bennett Comparison of cyclosporine nephrotoxicity with aminoglycoside nephrotoxicity Clin. Nephrol. 1986 25 Suppl 1 S126 S129
44. S. Cuzzocrea E. Mazzon L. Dugo I. Serraino R. Di Paola D. Britti A. De Sarro S. Pierpaoli A. Caputi E. Masini D. Salvemini A role for superoxide in gentamicin-mediated nephropathy in rats Eur. J. Pharmacol. 2002 450 67 76